tiprankstipranks
Erasca announces clinical progress for naporafenib
PremiumThe FlyErasca announces clinical progress for naporafenib
3M ago
Erasca to present preliminary SEACRAFT-1 Phase 1 data
Premium
The Fly
Erasca to present preliminary SEACRAFT-1 Phase 1 data
4M ago
Erasca participates in a conference call with JPMorgan
Premium
The Fly
Erasca participates in a conference call with JPMorgan
4M ago
Erasca 86.5M share Secondary priced at $1.85
PremiumThe FlyErasca 86.5M share Secondary priced at $1.85
8M ago
Erasca announces strategic in-licensing of RAS-targeting franchise
Premium
The Fly
Erasca announces strategic in-licensing of RAS-targeting franchise
8M ago
Erasca files to sell 21.07M shares of common stock for holders
Premium
The Fly
Erasca files to sell 21.07M shares of common stock for holders
8M ago
Capital One starts Erasca with Overweight into key data catalysts
PremiumThe FlyCapital One starts Erasca with Overweight into key data catalysts
10M ago
Erasca initiated with an Overweight at Capital One
Premium
The Fly
Erasca initiated with an Overweight at Capital One
10M ago
Erasca announces two CTCSAs with Novartis for trametinib
Premium
The Fly
Erasca announces two CTCSAs with Novartis for trametinib
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100